During the past decade, General Hospital of Ningxia Medical University conducted 118 clinical trials. In the 10-year time frame, 118 clinical trials started and 15 clinical trials were completed, i.e. on average, 12.7% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 11 clinical trials were completed. i.e. 16.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital of Ningxia Medical University" #1 sponsor was "General Hospital of Ningxia Medical University" with 38 trials, followed by "Takeda" with 6 trials sponsored, "Hepatopancreatobiliary Surgery Institute of Gansu Province" with 5 trials sponsored, "Bayer" with 4 trials sponsored and "BeiGene" with 4 trials sponsored. Other sponsors include 73 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital of Ningxia Medical University" #1 collaborator was "General Hospital of Ningxia Medical University" with 10 trials as a collaborator, "The First Hospital of Jilin University" with 6 trials as a collaborator, "Henan Provincial People's Hospital" with 5 trials as a collaborator, "The First Affiliated Hospital of Anhui Medical University" with 5 trials as a collaborator and "First Affiliated Hospital Xi'an Jiaotong University" with 4 trials as a collaborator. Other collaborators include 393 different institutions and companies that were collaborators in the rest 289 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital of Ningxia Medical University" are "Adverse Effect" (9 trials), "Coronary Artery Disease" (4 trials), "Cardiovascular Disease" (3 trials), "Idiopathic Pulmonary Fibrosis" (3 trials) and "Acute Coronary Syndrome" (2 trials). Many other conditions were trialed in "General Hospital of Ningxia Medical University" in a lesser frequency.

Most popular intervention types in "General Hospital of Ningxia Medical University" are "Drug" (84 trials), "Other" (14 trials), "Procedure" (10 trials), "Device" (8 trials) and "Diagnostic Test" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Norepinephrine" (5 trials), "Normal saline" (5 trials), "normal saline" (5 trials) and "Lansoprazole" (4 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital of Ningxia Medical University" are 118 trials for "All" genders, 16 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "General Hospital of Ningxia Medical University". 7 are not yet recruiting, 37 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 55 completed trials in General Hospital of Ningxia Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital of Ningxia Medical University, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 43 trials that are defined as “Not Applicable".

General Hospital of Ningxia Medical University has several departments that took part in Clinical trials: "Anesthesiology department of General Hospital of Ningxia Medical University" - 2 trials